Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Seeks To Nix Some Forms From Sunscreen Monograph

This article was originally published in The Tan Sheet

FDA’s advanced notice of proposed rulemaking starts the process of eliminating several other sunscreen delivery formats from the monograph, despite requests by marketers.

Wipes, towelettes, powders, body washes and shampoos will not be eligible for inclusion in the OTC sunscreen monograph if ANPR language survives the rulemaking process.

The only way FDA would allow these formats in the monograph is through time and extent applications.

The forms are not included because they were not marketed OTC before the drug review began, FDA said in the June 17 ANPR.

The agency’s decision means La Fresh and Supergoop! sunscreen wipes will not be allowed under the monograph. Nor will Innovative Skincare's iS Clinical sunscreen powders, Solise sunscreen body wash or many other products.

For TEAs, FDA considers five continuous years in same country as proof of a product meeting the “material time” standard.

For “material extent” proof, TEA sponsors must include information on markets where a product has been available to show that the information can be extrapolated to use of the product in the U.S.

By Elizabeth Crawford

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel